Last reviewed · How we verify
NCT03811275
Task or Virtual Reality Intervention for Improving UE Function
NA trial testing Virtual Reality (A) then Task (B) in Upper Extremity Paresis in 5 participants. Terminated before completion.
26 April 2024
Quick facts
| Lead sponsor | Idaho State University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 8 September 2018 |
| Primary completion | 26 April 2024 |
| Estimated completion | 26 April 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Virtual Reality (A) then Task (B)
- Task (B) then Virtual Reality (A)
Conditions studied
- Upper Extremity Paresis — all drugs for Upper Extremity Paresis →
- Hemiplegia and/or Hemiparesis Following Stroke — all drugs for Hemiplegia and/or Hemiparesis Following Stroke →
- Hemiplegic Cerebral Palsy — all drugs for Hemiplegic Cerebral Palsy →
Sponsor
Idaho State University
Who can join
Adults 18 to 89, any sex, with Upper Extremity Paresis or Hemiplegia and/or Hemiparesis Following Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
People with one arm that does not function well due to a stroke, head injury, or cerebral palsy, and a fully functional other arm, will be randomly assigned to receive one of the two interventions first, followed by the other intervention. The two interventions include a task-based intervention and a virtual reality intervention that provides a reflected image of the involved arm. The task-based intervention will consist of setting up activities of interest to be done using the involved arm and structuring practice and meaningful feedback to assist learning. The virtual reality intervention will consist of the person wearing the virtual reality device and practicing virtual tasks using the intact arm while seeing the involved arm. Intervention sessions will last approximately 30 minutes and will be held 3 times/week for 3 weeks each for a total of 9 sessions for each intervention. Testing of the involved arm's function will be done before the interventions, after receiving 9 sessions of each intervention, and one month after completing the second intervention received.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03811275
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Upper Extremity Paresis
Currently open trials in the same condition.
- NCT06574737 — Use of Surface Electromyography as a Tools to Predict Upper Extremity Recovery Function After Stroke · recruiting
- NCT06152328 — Virtual Reality Based Mirror Therapy · NA · recruiting
- NCT04534556 — Wireless Nerve Stimulation Device To Enhance Recovery After Stroke · NA · recruiting
- NCT04697368 — The Efficacy of Upper Limb Rehabilitation With Exoskeleton in Patients With Subacute Stroke. · NA · active not recruiting
- NCT03148106 — Hand Rehabilitation Study for Stroke Patients · NA · active not recruiting
Other Idaho State University trials
Trials by the same sponsor.
- NCT05850312 — Gamified Digital Intervention to Enhance the Efficacy of Exposure Therapy for OCD · NA · not yet recruiting
- NCT06279182 — Impact of Barre Stretching Among Dental Hygiene Students · NA · completed
- NCT06142292 — Mitigating Mental and Social Health Outcomes of COVID-19: a Counseling Approach · NA · completed
- NCT05873530 — Circadian Modulation of Grape Consumption and Oxidative Stress Response · NA · completed
- NCT05940077 — Community Exercise for Fall Risk in PD · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03811275 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Idaho State University
- Last refreshed: 30 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03811275.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing